Please assess the completion status of the following clinical trial:

Trial Title: Phase 1 Study of URC102 in Healthy Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy male volunteers~Exclusion Criteria:~* Received other investigational drug within 12 weeks prior to the first dose of study drug

- Gender: MALE
- Minimum Age: 20 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo
- URC102 (Type: ACTIVE_COMPARATOR): URC102

Based on this trial design, predict the completion outcome and termination type (if applicable).